Actively Recruiting
A Prospective Study of a Mosaic Embryo Transfer
Led by Colorado Center for Reproductive Medicine · Updated on 2024-02-29
250
Participants Needed
1
Research Sites
321 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research is a prospective study in which the purpose is to investigate the clinical outcomes following the transfer of a mosaic embryo (presence of both chromosomally normal and abnormal cells) that has been screened for preimplantation genetic testing (PGT).
CONDITIONS
Official Title
A Prospective Study of a Mosaic Embryo Transfer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 18 to 45 years who have completed an IVF cycle with preimplantation genetic testing (PGT) at the Colorado Center for Reproductive Medicine and have a mosaic embryo
- Patients of any race, culture, sexual orientation, or ethnicity
- Patients willing to transfer a single embryo
You will not qualify if you...
- Patients who do not meet clinical requirements for embryo transfer per clinic standards
- Patients desiring transfer of more than a single embryo
- Patients using a gestational carrier
- Embryonic mosaic PGT results showing chromosome errors 13, 18, or 21
- Patients who did not complete their IVF with PGT cycle at the Colorado Center for Reproductive Medicine
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Colorado Center for Reproductive Medicine
Lone Tree, Colorado, United States, 80124
Actively Recruiting
Research Team
R
Rachel Makloski, RN
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here